Neuromuscular and cardiovascular properties of ORG9426
Inst. of Anesthesiology, Univ. of Cologne, W-5000 Köln 41, FRG ORG9426 is a new steroidal non-depolarizing neuromuscular blocking drug currently undergoing phase-II clinical trials. Its onset of action is reported to be shorter than that of other available non-depolarizing agents1. We wanted to establish the ED95 and study neuromuscular (nm) and cardiovascular (cv) effects of ORG9426.
- Views Icon Views
- Share Icon Share
- Search Site
H. Mellinghoff, Ch. Diefenbach, W. Buzello; Neuromuscular and cardiovascular properties of ORG9426. Anesthesiology 1991; 75:A807 doi: https://doi.org/10.1097/00000542-199109001-00806
Download citation file: